SUBSEQUENT EVENTS (Details) - Neuraxpharm Agreement $ in Millions	1 Months Ended
	Jul. 31, 2023 USD ($)
Subsequent Event
Amount of one-time, non-refundable payment upon contract execution	$ 140.0
Additional payment upon first key market commercial launch	12.5
Additional milestone-based payments on achievement of certain launch and commercial milestones	$ 492.5
Percentage of digit royalties on net product sales	30.00%
Agreement Buyback Period	2 years